About SCHOTT Poonawalla
SCHOTT Poonawalla is a Healthcare company based in Mumbai (India) founded in 1990. Packaging solutions for pharmaceutical and biotech industries are provided. The company has 1,372 employees. Its Indian entity Schott Pharma India Private Limited reported revenue of ₹1,056 Cr. SCHOTT Poonawalla offers products and services including Syringes, Cartridges, Vials, Ampoules, and Regulatory Services. Its focus areas include Biopharma Outsourcing, Logistics & Supply Chain and Packaging. Its competitors include Ideal Cures, Natural Capsules and Cilicant; 1 of its 3 listed competitors has raised funding.
Company details
SCHOTT Poonawalla was established in 1990 in Mumbai, India, as a provider of packaging solutions for the pharmaceutical and biotech sectors. Primary packaging options such as cartridges, glass vials, ampoules, and prefillable syringes are included in its portfolio. Services encompassing drug development, research, analytical testing, and regulatory support are extended to pharmaceutical and biotech firms operating in these industries.
- Headquarters Mumbai, India
- Employees 1,372
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website schott-poonawalla.com/en
- Social LinkedIn
- Legal Name Schott Poonawalla Private Limited
- Date of Incorporation 21 Dec, 1994
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,056 Cr
FY 2025 · +12% YoY
- Net Profit₹222 Cr
FY 2025 · 21% margin
- EBITDA₹384 Cr
FY 2025 · 36% margin
- InvestorsSerum Institute of India
& 1 more
- Employee Count1,372
Associated legal entities of SCHOTT Poonawalla
SCHOTT Poonawalla operates through Schott Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Schott Pharma India Private Limited CIN U26100MH1994PTC083938 | Active | 21 Dec 1994 | Mumbai, Maharashtra | ₹1,056 Cr | 1,372 | 10 | View details |
Products & Services of SCHOTT Poonawalla
SCHOTT Poonawalla offers a comprehensive portfolio of products and services, including Syringes, Cartridges, Vials, Ampoules, and Regulatory Services.
Prefillable glass syringes for vaccines and injectables
Glass cartridges for peptide and protein-based drugs
Glass vials for secure storage of injectables
Glass ampoules for drug protection against counterfeiting
Services for drug master files and certificates
Funding Insights of SCHOTT Poonawalla
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of SCHOTT Poonawalla with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2025 | Private Equity Round | – | – | ||
| Aug 2021 | Unspecified | – | – |
2 investors in total: 2 institutional.
Investors in SCHOTT Poonawalla
SCHOTT Poonawalla has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Serum Institute of India and TPG Scion Unit Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vaccines and immuno-biological drugs for infectious diseases are manufactured. | 1966 | seruminstitute.com | Pune, India | |
Investor details for SCHOTT Poonawalla
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Schott Pharma India Private Limited (SCHOTT Poonawalla)
Schott Pharma India Private Limited is the primary company behind SCHOTT Poonawalla. The board of Schott Pharma India Private Limited currently have 7 directors; the longest-serving is Soumitra Bhattacharyya, appointed in 2025. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Soumitra Bhattacharyya DIN 02321355 | Director | 13 May 2025 | 1 yr 5 mo | Schott Pharma India Private Limited |
| Mahadevan Narayanamoni DIN 07128788 | Director | 13 May 2025 | 1 yr 5 mo | Schott Pharma India Private Limited |
| Bhushan Sudhir Bopardikar DIN 09089555 | Director | 13 May 2025 | 1 yr 5 mo | Schott Pharma India Private Limited |
| Fabian Stoecker DIN 11422192 | Additional Director | 15 Dec 2025 | 10 mo | Schott Pharma India Private Limited |
| Roy Joseph Manicknaparambil DIN 02984456 | Managing Director | 01 Jul 2026 | 4 mo | Schott Pharma India Private Limited |
| Dr Christian Alexander Mias DIN 11881716 | Additional Director | 24 Aug 2026 | 2 mo | Schott Pharma India Private Limited |
| Reinhard Josef Mayer DIN 00751360 | Additional Director | 07 Sep 2026 | 2 mo | Schott Pharma India Private Limited |
People of SCHOTT Poonawalla
1 people are tracked at SCHOTT Poonawalla (1 in leadership); the tracked headcount is 1,372.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for SCHOTT Poonawalla
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SCHOTT Poonawalla
Figures of Schott Pharma India Private Limited, the primary company behind SCHOTT Poonawalla, for FY 2025. Revenue was ₹1,056 Cr (+12% year on year). Net profit was ₹222 Cr (21% margin). EBITDA was ₹384 Cr (36% margin). Revenue has grown at a compounded annual rate of +3% over three years and +12% over five years.
- ₹1,056 CrRevenue · FY 2025 · +12% YoY
- ₹222 CrNet profit · 21% margin
- ₹384 CrEBITDA · 36% margin
- ₹32.2 LakhPaid-up capital
- 1,372Employees (provident fund records)
- +3%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Schott Pharma India Private Limited are on its company page.
Detailed financial statements for SCHOTT Poonawalla
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of SCHOTT Poonawalla
3 dated milestones of SCHOTT Poonawalla across 35 years, from founding to its latest funding, stage changes and deals.
- Founded SCHOTT Poonawalla is founded.
- Funding First funding round.
- Funding Latest funding round, Private Equity Round,.
Competitors of SCHOTT Poonawalla
SCHOTT Poonawalla has 3 listed competitors in our database, 1 of them funded. They include Ideal Cures, Natural Capsules and Cilicant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| idealcures.com | 1999 | Mumbai, India | Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms | |||
| naturalcapsules.com | 1993 | Bengaluru, India | 99 | Manufacturing and supply chain services for biopharma sector are provided. | ||
| cilicant.com | 2011 | Pune, India | $2M | 283 | Drugs for the biopharma sector are manufactured and supplied. |
Detailed competitors of SCHOTT Poonawalla
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SCHOTT Poonawalla
The website of SCHOTT Poonawalla (schott-poonawalla.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 6.5% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as SCHOTT Poonawalla (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Schott Poonawalla
Complete news archive for SCHOTT Poonawalla
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SCHOTT Poonawalla
SCHOTT Poonawalla was founded in 1990 and raised its 1st funding round 31 years after it was founded.
SCHOTT Poonawalla is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
SCHOTT Poonawalla has 1,372 employees.
The primary company behind SCHOTT Poonawalla, Schott Pharma India Private Limited, reported revenue of ₹1,056 Cr for FY 2025, up 12% year on year.
SCHOTT Poonawalla was established in 1990 in Mumbai, India, as a provider of packaging solutions for the pharmaceutical and biotech sectors. Primary packaging options such as cartridges, glass vials, ampoules, and prefillable syringes are included in its portfolio. Services encompassing drug development, research, analytical testing, and regulatory support are extended to pharmaceutical and biotech firms operating in these industries.
SCHOTT Poonawalla's top competitors include Natural Capsules, Ideal Cures and Cilicant.
SCHOTT Poonawalla offers Syringes, Cartridges, Vials, Ampoules, and Regulatory Services.
SCHOTT Poonawalla has 2 investors. Key investors include Serum Institute of India, and TPG Scion Unit Trust.
SCHOTT Poonawalla operates through Schott Pharma India Private Limited.
The legal entities of SCHOTT Poonawalla currently have 9 directors, including Rohit Avinash Sarmalkar, Fabian Stoecker, Soumitra Bhattacharyya and others.